<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The diagnosis of subtle structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> in competitive athletes with <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> (VAs) and an apparently <z:mpath ids='MPATH_458'>normal</z:mpath> heart is challenging </plain></SENT>
<SENT sid="1" pm="."><plain>Three-dimensional electroanatomic mapping (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>) has been demonstrated to reliably identify low-voltage areas that correspond to different cardiomyopathic substrates </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: The purpose of this study was to test whether <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> may help in the diagnosis of concealed <z:hpo ids='HP_0001638'>cardiomyopathies</z:hpo> in athletes with VAs and an apparently <z:mpath ids='MPATH_458'>normal</z:mpath> heart </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We studied 13 consecutive competitive athletes (12 males, age 30 Â± 13 years) who had documentation of VAs within the previous 6 months on 12-lead electrocardiogram (ECG), 24-hour Holter ECG, or ECG exercise testing and who were judged as having a structurally <z:mpath ids='MPATH_458'>normal</z:mpath> heart after a thorough noninvasive evaluation, including signal-averaged ECG, transthoracic echocardiogram, and cardiac magnetic resonance imaging </plain></SENT>
<SENT sid="4" pm="."><plain>Depending on the presumed site of VA origin according to 12-lead ECG criteria, patients underwent right or left ventricular <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>-guided endomyocardial biopsy </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Presenting <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> included sustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (n = 3), multiple episodes of nonsustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (n = 7), and frequent <z:mp ids='MP_0009732'>ventricular ectopic beats</z:mp> (&gt;1,000 during 24 hours; n = 3) </plain></SENT>
<SENT sid="6" pm="."><plain>Three patients had a history of <z:hpo ids='HP_0001279'>syncope</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Twelve (92%) patients had at least one low-voltage region at <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>, which corresponded at <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>-guided endomyocardial biopsy to the histological diagnosis of active <z:mp ids='MP_0001856'>myocarditis</z:mp> in seven patients and of <z:hpo ids='HP_0011663'>arrhythmogenic right ventricular cardiomyopathy</z:hpo> in five </plain></SENT>
<SENT sid="8" pm="."><plain>In one patient the histological evidence of contraction band <z:mp ids='MP_0001651'>necrosis</z:mp> allowed the unmasking of <z:chebi fb="111" ids="27732">caffeine</z:chebi> and ephedrine abuse </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Electroanatomical substrate mapping may help diagnose concealed <z:e sem="disease" ids="C0878544" disease_type="Disease or Syndrome" abbrv="">myocardial diseases</z:e> in competitive athletes presenting with recent-<z:hpo ids='HP_0003674'>onset</z:hpo> VAs and an apparently <z:mpath ids='MPATH_458'>normal</z:mpath> heart </plain></SENT>
<SENT sid="10" pm="."><plain>Further studies are warranted to assess the prognostic implications of such subtle myocardial abnormalities </plain></SENT>
</text></document>